The Use of an Effective Scale in the Evaluation of Hepatosteatosis in Psoriatic Arthritis: Tissue Attenuation Imaging HEPATOSTEATOZ DEĞERLENDİRMEDE ETKİN BİR ÖLÇEĞİN PSÖRİATİK ARTRİTLİ HASTALARDA KULLANIMI: DOKU ATENUASYON GÖRÜNTÜLEME

Creative Commons License

YILDIRIM D., TAMER A., CERİT M. N., KÜÇÜK H., ŞENDUR H. N.

Journal of Kirikkale University Faculty of Medicine, cilt.26, sa.2, ss.136-141, 2024 (Scopus, TRDizin)

Özet

Objective: Psoriatic arthritis (PsA) is a chronic destructive arthropathy with various types of joint involvement, which presents challenges in treatment management. Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity in patients with psoriatic arthritis. This study aims to evaluate the sensitivity of Tissue Attenuation Imaging (TAI) scores for NAFLD in PsA patients and assess their correlation with disease activity and laboratory values. Material and Methods: The study was conducted in collaboration with the Rheumatology and Radiology clinics of Gazi University from January 2023 to July 2023. A total of 25 PsA patients diagnosed according to CLASsification for Psoriatic ARthritis (CASPAR) criteria were included. Demographic data, disease activities, and laboratory values of the patients were recorded. TAI scores were compared between groups with and without NAFLD. Results: TAI scores were significantly higher in PsA patients with NAFLD (p=0.006). GGT, ESR (erythrocyte sedimentation rate), and hemoglobin levels were higher in those with NAFLD (p=0.002, 0.004 and 0.019). TAI score showed a positive correlation with triglyceride, GGT, and ESR values Conclusion: This study demonstrates the effectiveness of TAI scores in evaluating NAFLD in PsA patients. This non-invasive and quantitative assessment method, can aid in the monitoring of patients. Early detection of NAFLD in PsA patients is crucial to prevent complications.